rs162209

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000844.4(GRM7):​c.2698+19915G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.465 in 151,924 control chromosomes in the GnomAD database, including 17,243 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.46 ( 17243 hom., cov: 31)

Consequence

GRM7
NM_000844.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0640

Publications

2 publications found
Variant links:
Genes affected
GRM7 (HGNC:4599): (glutamate metabotropic receptor 7) L-glutamate is the major excitatory neurotransmitter in the central nervous system, and it activates both ionotropic and metabotropic glutamate receptors. Glutamatergic neurotransmission is involved in most aspects of normal brain function and can be perturbed in many neuropathologic conditions. The metabotropic glutamate receptors are a family of G protein-coupled receptors that have been divided into three groups on the basis of sequence homology, putative signal transduction mechanisms, and pharmacologic properties. Group I includes GRM1 and GRM5, and these receptors have been shown to activate phospholipase C. Group II includes GRM2 and GRM3, while Group III includes GRM4, GRM6, GRM7 and GRM8. Group II and III receptors are linked to the inhibition of the cyclic AMP cascade but differ in their agonist selectivities. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2009]
GRM7 Gene-Disease associations (from GenCC):
  • neurodevelopmental disorder with seizures, hypotonia, and brain imaging abnormalities
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.781 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GRM7NM_000844.4 linkc.2698+19915G>A intron_variant Intron 9 of 9 ENST00000357716.9 NP_000835.1 Q14831-1B2R693Q59G95
GRM7NM_181874.3 linkc.*21+13762G>A intron_variant Intron 10 of 10 NP_870989.1 Q14831-2B2R693B9EGG9
GRM7XM_017006272.2 linkc.*21+13762G>A intron_variant Intron 10 of 10 XP_016861761.1
GRM7XM_017006273.2 linkc.2200+19915G>A intron_variant Intron 9 of 9 XP_016861762.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GRM7ENST00000357716.9 linkc.2698+19915G>A intron_variant Intron 9 of 9 1 NM_000844.4 ENSP00000350348.4 Q14831-1

Frequencies

GnomAD3 genomes
AF:
0.464
AC:
70502
AN:
151806
Hom.:
17220
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.555
Gnomad AMI
AF:
0.270
Gnomad AMR
AF:
0.513
Gnomad ASJ
AF:
0.514
Gnomad EAS
AF:
0.801
Gnomad SAS
AF:
0.571
Gnomad FIN
AF:
0.460
Gnomad MID
AF:
0.522
Gnomad NFE
AF:
0.366
Gnomad OTH
AF:
0.469
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.465
AC:
70570
AN:
151924
Hom.:
17243
Cov.:
31
AF XY:
0.474
AC XY:
35190
AN XY:
74246
show subpopulations
African (AFR)
AF:
0.555
AC:
22967
AN:
41404
American (AMR)
AF:
0.513
AC:
7836
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.514
AC:
1783
AN:
3470
East Asian (EAS)
AF:
0.801
AC:
4111
AN:
5132
South Asian (SAS)
AF:
0.570
AC:
2747
AN:
4818
European-Finnish (FIN)
AF:
0.460
AC:
4863
AN:
10568
Middle Eastern (MID)
AF:
0.531
AC:
154
AN:
290
European-Non Finnish (NFE)
AF:
0.366
AC:
24855
AN:
67954
Other (OTH)
AF:
0.477
AC:
1008
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1859
3718
5576
7435
9294
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
642
1284
1926
2568
3210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.409
Hom.:
42627
Bravo
AF:
0.476
Asia WGS
AF:
0.692
AC:
2405
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
0.72
DANN
Benign
0.58
PhyloP100
0.064
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs162209; hg19: chr3-7741897; API